Ayumit Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-06-2024
- Paid Up Capital ₹ 0.50 M
as on 20-06-2024
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 20-06-2024
- Revenue 15.20%
(FY 2020)
- Profit 15.68%
(FY 2020)
- Ebitda 22.41%
(FY 2020)
- Net Worth 18.10%
(FY 2020)
- Total Assets 4.08%
(FY 2020)
About Ayumit Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹5.00 M.
Abshar Shakil, Veena Gupta, and Bhola Gupta serve as directors at the Company.
- CIN/LLPIN
U85100BR2014PTC023044
- Company No.
023044
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ayumit Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abshar Shakil  | Director | 27-Oct-2020 | Current |
| Veena Gupta | Director | 01-Apr-2015 | Current |
| Bhola Gupta | Director | 09-Oct-2014 | Current |
Financial Performance of Ayumit Healthcare.
Ayumit Healthcare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 15.2% increase. The company also saw a substantial improvement in profitability, with a 15.68% increase in profit. The company's net worth Soared by an impressive increase of 18.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ayumit Healthcare?
In 2020, Ayumit Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Exalt Pharmaceuticals Private LimitedActive 10 years 1 month
Veena Gupta and Bhola Gupta are mutual person
- Gargill Infrastructure Private LimitedActive 5 years 10 months
Veena Gupta and Bhola Gupta are mutual person
- Novotel Pharmaceuticals Private LimitedActive 4 years 1 month
Veena Gupta and Bhola Gupta are mutual person
- Glato Foodgrains Private LimitedActive 3 years 3 months
Veena Gupta and Bhola Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 09 Jun 2017 | ₹5.00 M | Open |
How Many Employees Work at Ayumit Healthcare?
Unlock and access historical data on people associated with Ayumit Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ayumit Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayumit Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
